Latest Period
Q1 2026
Security Snapshot
LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) Institutional Ownership
CUSIP: 539319301
13F Institutional Holders and Ownership History from Q2 2023 to Q1 2026
Institutions Reporting
14
Shares (Excl. Options)
732,501
Price
$3.07
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- LIXT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 732,501
- Total 13F value
- $2,247,945
- Portfolio coverage rank
- 0%
- Share change
- -32,451
- Value change
- -$172,595
- Number of holders
- 14
- Shares outstanding
- 15,194,157
- SEC-reported price per share
- $5.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 539319301.
- 14 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 17 to 14 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,968,653 to $2,247,945.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 14 institutions filings for Q1 2026.
Security key
539319301
Latest holder period
Q1 2026
13F holders
14
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
LIXT full holder history
LIXTE BIOTECHNOLOGY HOLDINGS, INC. SEC filings
LIXTE BIOTECHNOLOGY HOLDINGS, INC. company facts
LIXTE BIOTECHNOLOGY HOLDINGS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 539319301:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
LIXT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Strategic EP, LLC | 5.1% | $3,928,753 | 774,902 | Strategic EP, LLC | 04 Jun 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 5% | $181,780 | 138,763 | Mitchell P. Kopin | 11 Feb 2025 | |||
| Orca Capital AG | 4.5% | -45% | $157,216 | -$127,568 | 120,012 | -45% | Orca Capital AG | 14 Feb 2025 |
As of 31 Mar 2026, 14 institutional investors reported holding 732,501 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT). This represents 4.8% of the company’s total 15,194,157 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Latest
Q1 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 732,501 | $2,247,945 | -$172,595 | $3.07 | 14 |
| 2025 Q4 | 755,383 | $2,968,653 | +$1,130,402 | $3.93 | 17 |
| 2025 Q3 | 438,741 | $2,207,346 | +$1,384,461 | $5.03 | 16 |
| 2025 Q2 | 163,636 | $148,054 | -$163,058 | $0.90 | 10 |
| 2025 Q1 | 300,011 | $384,657 | -$81,359 | $1.21 | 9 |
| 2024 Q4 | 297,557 | $607,533 | +$138,617 | $2.03 | 10 |
| 2024 Q3 | 215,532 | $409,125 | +$72,342 | $1.87 | 7 |
| 2024 Q2 | 178,383 | $424,174 | +$88,625 | $2.37 | 6 |
| 2024 Q1 | 138,296 | $467,369 | +$81,413 | $3.38 | 6 |
| 2023 Q4 | 114,289 | $267,989 | +$177,089 | $2.34 | 6 |
| 2023 Q3 | 37,983 | $92,809 | +$15,777 | $2.45 | 6 |
| 2023 Q2 | 17,340 | $101,452 | +$101,452 | $5.88 | 5 |